Search Results

Phoenix Children’s Hospital recently announced Terrence L. Stull, MD as senior vice president of research and chief research officer. In this position, Dr. Stull is responsible for the direction and leadership of Phoenix Children’s Research Institute.

Angus A. Wilfong, MD, has joined Phoenix Children's Hospital as Chief of Pediatric Neurology at Barrow Neurological Institute at Phoenix Children’s. In this role, Dr. Wilfong will oversee all functions of the neurology practice including surgery, technology, innovation, and research and development.

Phoenix Children’s new 17,000-square-foot Center for Cancer and Blood Disorders (CCBD) will open to patients on October 18, increasing the Hospital’s capacity to care for children and adults fighting pediatric cancer and complex blood disorders.

Phoenix Children’s y United Healthcare anunciaron ayer que las dos organizaciones llegaron a un acuerdo para muchos años para asegurar que las familias a las que ambas organizaciones mutualmente atienden tengan acceso continuado sin interrupción para la atención que necesitan.

Phoenix Children’s, one of the nation’s largest and fastest-growing pediatric healthcare systems, today announced the retirement of Robert L. Meyer, who has served as the organization’s President and CEO for 22 years. Working closely with the Board of Directors to finalize the leadership transition process, including the selection of his replacement, Meyer will officially retire in the summer of 2025, marking the end of an exceptional leadership tenure that has shaped Phoenix Children’s into a nationally recognized institution for children's healthcare.

Located in Glendale, this state-of-the-art, 175,000-square-foot hospital offers a comprehensive range of services, including inpatient care, a 24/7 emergency department, surgical care and advanced imaging services. The new hospital will treat up to 72,000 patients annually and answers a pressing need for high-quality pediatric services in the West Valley.

This research provides new clarity on a rare, lethal, genetic lung disease which causes respiratory failure in newborns and infants. It also has implications for more common pulmonary disorders.